What's breaking now, across thousands of outlets.
→ Juan Andres will come out of retirement to rejoin Moderna as COO on Oct. 5, bringing his intimate knowledge of the company as its Merck-partnered cancer vaccine gathers momentum in the clinic. Andres first ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Abu Dhabi- Seha, subsidiary of PureHealth, an integrated healthcare platform in the Middle East, has successfully managed a rare and potentially life-threatening neurological case at Sheikh Tahnoon…
The alliance aims to address gaps in prevention, early detection, timely referral, multidisciplinary care and post-amputation rehabilitation
The alliance aims to address gaps in prevention, early detection, timely referral, multidisciplinary care and post-amputation rehabilitation
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS.
MILAN — As more GLP-1-based drugs reach late-stage trials and post stronger and stronger weight loss effects, companies that want to enter the market are looking for differentiating factors.
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
